Form EFFECT Scribe Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 23, 2026 4:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gallbladder Cancer Foundation and Citizen Health Expand Their Partnership to Put Ari to Work for Every Patient
- Tego AI Discloses Second Claude Flaw in a Week: Hidden Link Silently Sends Files to Attackers
- QSE Upsizes Private Placement Financing by 83% to $5.5 Million
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
